Mallinckrodt announces the 2024 Winner of the Extracorporeal Immunomodulation Award

This year’s award marks 30 years since clinicians first used ECP to successfully treat chronic graft versus host disease (cGvHD).1 In recognition of this important milestone, this year’s $75,000 grant was dedicated to advancing research in this important area. DUBLIN, Nov. 14, 2024…